WS #13403
Holding: newest synthesis is 98d 14h old
Novo Nordisk reported Q2 adjusted operating profit up 11% and raised its full-year outlook, driven by GLP-1 volume growth, positive for the pharma sector.
Novo Nordisk Earnings and Outlook
Novo Nordisk reported Q2 adjusted operating profit up 11% and raised its full-year outlook, driven by GLP-1 volume growth, positive for the pharma sector.